Market Place
Sourcing Support
Despite revision, UCPMP remains toothless: Alleges FMRAI
23 Jun 2025 //
PHARMABIZ
AbbVie Declares Quarterly Dividend
20 Jun 2025 //
PRESS RELEASE
AbbVie`s Migraine Drug Meets Main Goal in Head-To-Head Study
19 Jun 2025 //
PRESS RELEASE
AbbVie says blood cancer drug fails late-stage trial
16 Jun 2025 //
REUTERS
AbbVie Secures FDA Approval for Expanded Use of Mavyret
12 Jun 2025 //
PRESS RELEASE
AbbVie to Present at Goldman Sachs Healthcare Conference
03 Jun 2025 //
PRESS RELEASE
Abbvie Invites Migraine Sufferers to Enter Career Catalyst Award
03 Jun 2025 //
PRESS RELEASE
AbbVie flies the W against cancer with Chicago Cubs partnership
30 May 2025 //
FIERCE PHARMA
AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
30 May 2025 //
PR NEWSWIRE
AbbVie Showcases Data on Solid Tumors and Blood Cancers at ASCO
28 May 2025 //
PRESS RELEASE
AbbVie Showcases Data on Solid Tumors and Blood Cancers at ASCO
27 May 2025 //
PRESS RELEASE
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
15 May 2025 //
PRESS RELEASE
US FDA approves AbbVie`s drug for a type of lung cancer
15 May 2025 //
PRESS RELEASE
AbbVie plant workers in Ireland plan to strike over pay issue
14 May 2025 //
FIERCE PHARMA
AbbVie again leads doctors` perception of immunology drugmakers
12 May 2025 //
FIERCE PHARMA
Techbio Pioneer Etcembly Signs Deal With DJS Antibodies
12 May 2025 //
BUSINESSWIRE
AbbVie`s Biologics Skyrizi Receives Suppl Approval in US
07 May 2025 //
FDA
AbbVie to Present at Bank of America Healthcare Conference
06 May 2025 //
PRESS RELEASE
AbbVie’s Skyrizi retakes top TV ad spending spot in April
05 May 2025 //
FIERCE PHARMA
Botox Backs Entrepreneurs via Confidence Project
01 May 2025 //
PR NEWSWIRE
Rinvoq Recieves FDA approved for Giant Cell Arteritis
29 Apr 2025 //
PRESS RELEASE
AbbVie plots $10B US outlay as pharma tariff threat looms
26 Apr 2025 //
FIERCE PHARMA
AbbVie to First-Quarter 2025 Earnings Conference Call
26 Apr 2025 //
PRESS RELEASE
AbbVie Submits BLA for TrenibotE for Treatment of Glabellar
25 Apr 2025 //
PRESS RELEASE
AbbVie launches Venetoclax in India for AML and CLL
21 Apr 2025 //
EXPRESSPHARMA
ThirtyFiveBio closes bridge round with new investment from AbbVie
15 Apr 2025 //
PRESS RELEASE
AbbVie Announces EMA Approval of Rinvoqa For Giant Cell Arteritis
09 Apr 2025 //
PRESS RELEASE
AbbVie cuts 2025 profit forecast on acquisition expenses
03 Apr 2025 //
REUTERS
AbbVie to Host First-Quarter 2025 Earnings Conference Call
31 Mar 2025 //
PR NEWSWIRE
Regulatory Condition Met for AbbVie-Gubra License Agreement
28 Mar 2025 //
ACCESSWIRE
AbbVie Highlights Oncology Advances at AACR Meeting 2025
27 Mar 2025 //
PRESS RELEASE
Allergan Aesthetic` Innovation, Science, Patient Focus at AMWC 2025
24 Mar 2025 //
PR NEWSWIRE
Genmab To Defend Against Trade Secret Claims By AbbVie
21 Mar 2025 //
GLOBENEWSWIRE
ELAHERE® Shows Consistent Survival Benefit in Ovarian Cancer
15 Mar 2025 //
PR NEWSWIRE
AbbVie &Gubra Announce License Agreement to Develop an Amylin Analog
03 Mar 2025 //
PRESS RELEASE
Epkinely Gets Japan MHLW Approval For R/R Follicular Lymphoma
20 Feb 2025 //
GLOBENEWSWIRE
UCB’s Bimzelx outpacing AbbVie’s Rinvoq, Skyrizi on awareness
14 Feb 2025 //
FIERCE PHARMA
AbbVie Declares Quarterly Dividend
13 Feb 2025 //
PR NEWSWIRE
AbbVie Commits $2.1B to Revolutionary Tumor-Fighting Tech
13 Feb 2025 //
PRESS RELEASE
FDA Approves EMBLAVEO For Complicated Intra-Abdominal Infections
08 Feb 2025 //
INDPHARMAPOST
FDA approves AbbVie-Pfizer`s treatment for abdominal infections
08 Feb 2025 //
REUTERS
Allergan, ASPS, Aesthetic Society Release Videos for Women Surgeons
05 Feb 2025 //
PR NEWSWIRE
AbbVie projects over $31B in Skyrizi, Rinvoq sales by 2027
01 Feb 2025 //
FIERCE PHARMA
AbbVie Revamps Emraclidine Expectations After Schizophrenia Failure
31 Jan 2025 //
BIOSPACE
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
31 Jan 2025 //
PR NEWSWIRE
NMC Probes Doctors Over AbbVie-Sponsored Foreign Trips
24 Jan 2025 //
ECONOMICTIMES
Allergan`s AA Signature Program Unveiled At IMCAS 2025 Congress
24 Jan 2025 //
PR NEWSWIRE
AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
24 Jan 2025 //
PRESS RELEASE
AbbVie Completes Acquisition of Nimble Therapeutics
23 Jan 2025 //
PR NEWSWIRE
AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager
14 Jan 2025 //
PRESS RELEASE
AbCellera, AbbVie Partner to Develop Novel Oncology T-Cell Engagers
13 Jan 2025 //
BUSINESSWIRE
Abbvie to record $3.5 bln charge related to schizophrenia drug
11 Jan 2025 //
REUTERS
AbbVie to Present at Annual J.P. Morgan Healthcare Conference
09 Jan 2025 //
PR NEWSWIRE
AbbVie first $40 M to advance Capsida-partnered CNS gene therapy
08 Jan 2025 //
FIERCE BIOTECH
AbbVie cuts 2024 profit forecast on acquisition expenses
07 Jan 2025 //
REUTERS
AbbVie to Host Full-Year and Q4 2024 Earnings Conference Call
03 Jan 2025 //
PR NEWSWIRE
Pharma Dept Reprimands AbbVie for Unethical Marketing Practices
24 Dec 2024 //
BUSINESS STD
AbbVie Healthcare under government lens for `violations`
23 Dec 2024 //
ECONOMICTIMES
Novartis, AbbVie & PhRMA secure 340B court win in West Virginia
19 Dec 2024 //
ENDPTS
AbbVie buys Roche spinout Nimble Therapeutics for $200M
14 Dec 2024 //
PRESS RELEASE
